Misplaced Pages

CS-27349

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
CS-27349
Identifiers
IUPAC name
  • (1R,2R,5S)-8-Methyl-8-azabicyclooct-2-yl hydroxy(diphenyl)acetate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H25NO3
Molar mass351.446 g·mol
3D model (JSmol)
SMILES
  • CN1C2CC(C1CC2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.Cl
InChI
  • InChI=1S/C22H25NO3/c1-23-18-12-14-19(23)20(15-13-18)26-21(24)22(25,16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-20,25H,12-15H2,1H3/t18?,19?,20-/m1/s1
  • Key:LSJGAYNIIMEDLR-SOAGJPPSSA-N

CS-27349, or L-2-α-tropinyl benzilate, is an experimental incapacitating agent. It acts as an antagonist to muscarinic acetylcholine receptors, causing delirium. It has 37% of the potency of the related compound 3-quinuclidinyl benzilate (BZ) in producing peripheral effects, but 85% of the potency in producing central effects. The mean dose required to incapacitate subjects was 1.2 times that of BZ. It has not been in use since the 1970s, and there have been no publications about its effects or long-term toxicology since then.

References

  1. Ball JC (2015). "Dual Use Research of Concern: Derivatives of 3-Quinuclidinyl Benzilate". Military Medical Science Letters. 84 (1): 2–41. doi:10.31482/mmsl.2015.001.
  2. Assessment of Potential Long-Term Health Effects on Army Human Test Subjects of Relevant Biological and Chemical Agents, Drugs, Medications and Substances (PDF) (Report). Ho-Chunk Technical Solutions Healthcare Division. February 29, 2016. Archived (PDF) from the original on December 25, 2020.
Blood agents
Blister agents
Arsenicals
  • Ethyldichloroarsine (ED)
  • Methyldichloroarsine (MD)
  • Phenyldichloroarsine (PD)
  • Lewisite (L)
  • Lewisite 2 (L2)
  • Lewisite 3 (L3)
  • Sulfur mustards
    Nitrogen mustards
    Nettle agents
    Other
    Nerve agents
    G-agents
    V-agents
    GV agents
    Novichok agents
    Carbamates
    Other
    Precursors
    Neurotoxins
    Pulmonary/
    choking agents
    Vomiting agents
    Incapacitating
    agents
    Lachrymatory
    agents
    Malodorant agents
    Cornea-clouding agents
    Biological toxins
    Other
    Hallucinogens
    Psychedelics
    (5-HT2A
    agonists)
    Benzofurans
    Lyserg‐
    amides
    Phenethyl‐
    amines
    2C-x
    25x-NBx
    25x-NB
    25x-NB3OMe
    25x-NB4OMe
    25x-NBF
    25x-NBMD
    25x-NBOH
    25x-NBOMe
    Atypical structures
    25x-NMx
    N-(2C)-fentanyl
    3C-x
    4C-x
    DOx
    HOT-x
    MDxx
    Mescaline (subst.)
    TMAs
    • TMA
    • TMA-2
    • TMA-3
    • TMA-4
    • TMA-5
    • TMA-6
    Others
    Piperazines
    Tryptamines
    alpha-alkyltryptamines
    x-DALT
    x-DET
    x-DiPT
    x-DMT
    x-DPT
    Ibogaine-related
    x-MET
    x-MiPT
    Others
    Others
    Dissociatives
    (NMDAR
    antagonists)
    Arylcyclo‐
    hexylamines
    Ketamine-related
    PCP-related
    Others
    Adamantanes
    Diarylethylamines
    Morphinans
    Others
    Deliriants
    (mAChR
    antagonists)
    Others
    Cannabinoids
    (CB1 agonists)
    Natural
    Synthetic
    AM-x
    CP x
    HU-x
    JWH-x
    Misc. designer cannabinoids
    D2 agonists
    GABAA
    enhancers
    Inhalants
    (Mixed MOA)
    κOR agonists
    Oneirogens
    Others
    Muscarinic acetylcholine receptor modulators
    mAChRsTooltip Muscarinic acetylcholine receptors
    Agonists
    Antagonists
    Precursors
    (and prodrugs)
    See also
    Receptor/signaling modulators
    Nicotinic acetylcholine receptor modulators
    Acetylcholine metabolism/transport modulators


    Stub icon

    This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

    Categories:
    CS-27349 Add topic